These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26139334)

  • 21. [Systemic sclerosis - diagnosis and classification].
    Genth E; Krieg T
    Z Rheumatol; 2006 Jul; 65(4):268-74. PubMed ID: 16804700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scleroderma autoantibodies in guiding monitoring and treatment decisions.
    Shah S; Denton CP
    Curr Opin Rheumatol; 2022 Nov; 34(6):302-310. PubMed ID: 36082759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Systemic sclerosis. Current classification and diagnosis of organ involvement].
    Persa OD; Moinzadeh P; Hunzelmann N
    Hautarzt; 2015 Aug; 66(8):599-603. PubMed ID: 26115973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.
    Villalta D; Imbastaro T; Di Giovanni S; Lauriti C; Gabini M; Turi MC; Bizzaro N
    Autoimmun Rev; 2012 Dec; 12(2):114-20. PubMed ID: 22776784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
    Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
    Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
    Yanaba K
    J Dermatol; 2016 Jan; 43(1):46-55. PubMed ID: 26782006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
    Pauling JD; Salazar G; Lu H; Betteridge ZE; Assassi S; Mayes MD; McHugh NJ
    Rheumatology (Oxford); 2018 Apr; 57(4):712-717. PubMed ID: 29294089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Scleroderma associated autoantibodies - clinical and diagnostic relevance].
    Mierau R; Genth E
    Z Rheumatol; 2006 Jul; 65(4):279-84. PubMed ID: 16788839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
    Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
    Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunopathogenesis of Juvenile Systemic Sclerosis.
    Stevens AM; Torok KS; Li SC; Taber SF; Lu TT; Zulian F
    Front Immunol; 2019; 10():1352. PubMed ID: 31293569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticentromere-A and anticentromere-B antibodies show high concordance and similar clinical associations in patients with systemic sclerosis.
    Hanke K; Becker MO; Brueckner CS; Meyer W; Janssen A; Schlumberger W; Hiepe F; Burmester GR; Riemekasten G
    J Rheumatol; 2010 Dec; 37(12):2548-52. PubMed ID: 20889593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Child-onset systemic sclerosis positive for anticentromere antibodies: two Japanese cases.
    Inamo Y
    Pediatr Int; 2012 Dec; 54(6):941-4. PubMed ID: 23279029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic trials for systemic sclerosis: an update.
    Sardana K; Garg VK
    Indian J Dermatol Venereol Leprol; 2008; 74(5):436-46. PubMed ID: 19052400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.
    Affandi AJ; Radstake TR; Marut W
    Semin Immunopathol; 2015 Sep; 37(5):475-87. PubMed ID: 26168983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies.
    Koenig M; Dieudé M; Senécal JL
    Autoimmun Rev; 2008 Sep; 7(8):588-93. PubMed ID: 18617021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of morphea and systemic sclerosis.
    Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y
    Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Systemic sclerosis. A rare connective tissue disease with manifestations in many organs].
    Haugeberg G; Brodin C; Johnsen V
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3619-21. PubMed ID: 8539716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in the diagnosis and treatment of systemic sclerosis.
    Kowal-Bielecka O; Bielecki M; Kowal K
    Pol Arch Med Wewn; 2013; 123(1-2):51-8. PubMed ID: 23344666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.
    Peterson LK; Jaskowski TD; Mayes MD; Tebo AE
    Immunol Res; 2016 Apr; 64(2):483-8. PubMed ID: 26467972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.